4-ACETYLPHENYLBORONIC ACID, PINACOL ESTER
Product Information
Molecular Formula
C14H19BO3
Molecular Weight
246.11
Description
4-ACETYLPHENYLBORONIC ACID, PINACOL ESTER is a key intermediate in biomedicine and used for the synthesis of novel pharmaceutical agents. It plays a vital role in developing drugs for the treatment of various diseases such as cancer, diabetes, and inflammatory disorders. With its unique chemical structure, this compound exhibits potent therapeutic potential and serves as a valuable tool for biomedical research in the quest for new treatment options.
Synonyms
1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethanone; 1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanone; 4-Acetylphenylboronic acid, pinacol ester; 4-Acetylphenylboronic acid pinacol ester; (4-ACETYLPHENYL)BORONIC ACID PINACOL ESTER; 1-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethan-1-one; 1-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethan-1-one; 4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2yl)phenyl-ethanone; 4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2yl)phenylethanone; 2-(4-ACETYLPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE; 1-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethanone
IUPAC Name
1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethanone
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC=C(C=C2)C(=O)C
InChI
InChI=1S/C14H19BO3/c1-10(16)11-6-8-12(9-7-11)15-17-13(2,3)14(4,5)18-15/h6-9H,1-5H3
InChI Key
BATKIZWNRQGSKE-UHFFFAOYSA-N
Flash Point
Not applicable
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
2
Exact Mass
246.1427246 g/mol
Monoisotopic Mass
246.1427246 g/mol
Topological Polar Surface Area
35.5Ų
Heavy Atom Count
18
Formal Charge
0
Complexity
314
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-113956274-A | Design and synthesis method of fluorescent probe capable of responding to viscosity and peroxynitrite change in epileptic diseases | 2021-10-29 |
| KR-102274449-B1 | Fluoranthene compound and organic light emitting element comprising the same | 2019-11-05 |
| KR-20210054300-A | Fluoranthene compound and organic light emitting element comprising the same | 2019-11-05 |
| TW-202016109-A | Pyrrolo[2,3-B]pyridine or pyrrolo[2,3-B]pyrazine as an HPK1 inhibitor and uses thereof | 2018-06-13 |
| CN-112004816-A | PRC2 inhibitors | 2018-01-31 |
| KR-20200115570-A | PRC2 inhibitor | 2018-01-31 |
| BR-112020015583-A2 | compound, pharmaceutical composition, and, methods to inhibit the activity of prc2 in a cell and to treat cancer | 2018-01-31 |
| US-2021032252-A1 | PRC2 Inhibitors | 2018-01-31 |
| US-2021101904-A1 | Prc2 inhibitors | 2018-01-31 |
| IL-276156-A | PRC2 drives | 2018-01-31 |
